JP2020531486A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020531486A5 JP2020531486A5 JP2020510096A JP2020510096A JP2020531486A5 JP 2020531486 A5 JP2020531486 A5 JP 2020531486A5 JP 2020510096 A JP2020510096 A JP 2020510096A JP 2020510096 A JP2020510096 A JP 2020510096A JP 2020531486 A5 JP2020531486 A5 JP 2020531486A5
- Authority
- JP
- Japan
- Prior art keywords
- pyridyl
- pyridine
- oxo
- trifluoromethyl
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 Cc1ccc(**)cc1C Chemical compound Cc1ccc(**)cc1C 0.000 description 5
- VQTVFIMEENGCJA-UHFFFAOYSA-N Cc1c[nH]nc1C Chemical compound Cc1c[nH]nc1C VQTVFIMEENGCJA-UHFFFAOYSA-N 0.000 description 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022198540A JP2023021276A (ja) | 2017-08-23 | 2022-12-13 | ピリジルピリドン化合物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17187544.6 | 2017-08-23 | ||
| EP17187544 | 2017-08-23 | ||
| PCT/EP2018/072788 WO2019038387A1 (en) | 2017-08-23 | 2018-08-23 | PYRIDYLPYRIDONE COMPOUNDS |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022198540A Division JP2023021276A (ja) | 2017-08-23 | 2022-12-13 | ピリジルピリドン化合物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020531486A JP2020531486A (ja) | 2020-11-05 |
| JP2020531486A5 true JP2020531486A5 (enExample) | 2022-10-20 |
| JP7199737B2 JP7199737B2 (ja) | 2023-01-06 |
Family
ID=59686881
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020510096A Active JP7199737B2 (ja) | 2017-08-23 | 2018-08-23 | ピリジルピリドン化合物 |
| JP2022198540A Pending JP2023021276A (ja) | 2017-08-23 | 2022-12-13 | ピリジルピリドン化合物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022198540A Pending JP2023021276A (ja) | 2017-08-23 | 2022-12-13 | ピリジルピリドン化合物 |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US11219618B2 (enExample) |
| EP (2) | EP4056556A1 (enExample) |
| JP (2) | JP7199737B2 (enExample) |
| KR (1) | KR102730718B1 (enExample) |
| CN (3) | CN111094244B (enExample) |
| AU (2) | AU2018320416B2 (enExample) |
| CY (1) | CY1125138T1 (enExample) |
| DK (1) | DK3672941T3 (enExample) |
| ES (1) | ES2910839T3 (enExample) |
| HR (1) | HRP20220571T1 (enExample) |
| HU (1) | HUE058977T2 (enExample) |
| IL (3) | IL302356A (enExample) |
| LT (1) | LT3672941T (enExample) |
| PL (1) | PL3672941T3 (enExample) |
| PT (1) | PT3672941T (enExample) |
| RS (1) | RS63161B1 (enExample) |
| SI (1) | SI3672941T1 (enExample) |
| SM (1) | SMT202200183T1 (enExample) |
| TW (2) | TWI787335B (enExample) |
| WO (1) | WO2019038387A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112020012651A2 (pt) | 2017-12-22 | 2020-12-01 | Ravenna Pharmaceuticals, Inc. | compostos derivados de aril-bipiridina amina como inibidores da fosfatidilinositol fosfato quinase, composição farmacêutica compreendendo os mesmos e usos terapêuticos dos ditos compostos |
| JP2023550638A (ja) | 2020-11-25 | 2023-12-04 | デシフェラ・ファーマシューティカルズ，エルエルシー | ウイルス感染症の処置に使用するための、ｖｓｐ３４阻害剤としてのモルホリノ誘導体 |
| CN117083064A (zh) | 2020-11-25 | 2023-11-17 | 德西费拉制药有限责任公司 | 作为vps34抑制剂用于治疗病毒感染的吡啶基吡啶酮衍生物 |
| CA3228766A1 (en) * | 2021-08-13 | 2023-02-16 | Yasmin YU | Combination therapy of vps34 inhibitors and sting agonist for use in the treatment of cancer |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA04011470A (es) * | 2002-05-21 | 2005-02-14 | Amgen Inc | Compuestos heterociclicos sustituidos y metodos de uso. |
| TW200908984A (en) * | 2007-08-07 | 2009-03-01 | Piramal Life Sciences Ltd | Pyridyl derivatives, their preparation and use |
| EA201390917A1 (ru) * | 2010-12-21 | 2013-12-30 | Новартис Аг | Дигетероарильные соединения в качестве ингибиторов vps34 |
| PT2655375E (pt) | 2010-12-23 | 2015-03-02 | Sanofi Sa | Derivados de pirimidinona, sua preparação e sua utilização farmacêutica |
| GB201120317D0 (en) | 2011-11-24 | 2012-01-04 | Queen Mary & Westfield College | Screening method |
| PE20150666A1 (es) * | 2012-03-01 | 2015-05-06 | Array Biopharma Inc | Inhibidores de serina/treonina cinasa |
| HK1208681A1 (en) * | 2012-06-12 | 2016-03-11 | Abbvie Inc. | Pyridinone and pyridazinone derivatives |
| FR2992314B1 (fr) | 2012-06-22 | 2015-10-16 | Sanofi Sa | Nouveaux derives de 2,3-dihydro-1h-imidazo{1,2-a}pyrimidin-5-one et 1,2,3,4-tetrahydro-pyrimido{1,2-a}pyrimidin-6-one comportant une morpholine substituee, leur preparation et leur utilisation pharmaceutique |
| WO2015108881A1 (en) | 2014-01-14 | 2015-07-23 | Millennium Pharmaceuticals, Inc. | Heteroaryls and uses thereof |
| TN2016000270A1 (en) * | 2014-01-14 | 2017-10-06 | Millennium Pharm Inc | Heteroaryls and uses thereof. |
| MA39823A (fr) | 2014-04-03 | 2018-01-09 | Janssen Pharmaceutica Nv | Dérivés de pyridine macrocyclique |
| MA39822A (fr) | 2014-04-03 | 2018-02-06 | Janssen Pharmaceutica Nv | Dérivés de pyrimidine bicycle |
| WO2016001789A1 (en) * | 2014-06-30 | 2016-01-07 | Pfizer Inc. | Pyrimidine derivatives as pi3k inhibitors for use in the treatment of cancer |
| PL3416945T3 (pl) * | 2016-02-19 | 2020-12-28 | Sprint Bioscience Ab | Związki 6-arylo-4-(morfolin-4-ylo)-1h-pirydyn-2-onu przydatne w leczeniu nowotworu i cukrzycy |
| PT3416957T (pt) | 2016-02-19 | 2020-09-25 | Sprint Bioscience Ab | Compostos 6-heterociclil-4-morfolin-4-ilpiridin-2-ona úteis para o tratamento do cancro e da diabetes |
-
2018
- 2018-08-23 IL IL302356A patent/IL302356A/en unknown
- 2018-08-23 EP EP22155562.6A patent/EP4056556A1/en not_active Withdrawn
- 2018-08-23 TW TW107129492A patent/TWI787335B/zh not_active IP Right Cessation
- 2018-08-23 SI SI201830631T patent/SI3672941T1/sl unknown
- 2018-08-23 RS RS20220398A patent/RS63161B1/sr unknown
- 2018-08-23 WO PCT/EP2018/072788 patent/WO2019038387A1/en not_active Ceased
- 2018-08-23 US US16/639,895 patent/US11219618B2/en active Active
- 2018-08-23 JP JP2020510096A patent/JP7199737B2/ja active Active
- 2018-08-23 CN CN201880059987.0A patent/CN111094244B/zh active Active
- 2018-08-23 PL PL18759308T patent/PL3672941T3/pl unknown
- 2018-08-23 LT LTEPPCT/EP2018/072788T patent/LT3672941T/lt unknown
- 2018-08-23 DK DK18759308.2T patent/DK3672941T3/da active
- 2018-08-23 HR HRP20220571TT patent/HRP20220571T1/hr unknown
- 2018-08-23 AU AU2018320416A patent/AU2018320416B2/en not_active Ceased
- 2018-08-23 SM SM20220183T patent/SMT202200183T1/it unknown
- 2018-08-23 TW TW111144233A patent/TW202308996A/zh unknown
- 2018-08-23 EP EP18759308.2A patent/EP3672941B1/en active Active
- 2018-08-23 CN CN202310818724.6A patent/CN116903526A/zh active Pending
- 2018-08-23 KR KR1020207006936A patent/KR102730718B1/ko active Active
- 2018-08-23 CN CN202310818638.5A patent/CN116891431A/zh active Pending
- 2018-08-23 HU HUE18759308A patent/HUE058977T2/hu unknown
- 2018-08-23 ES ES18759308T patent/ES2910839T3/es active Active
- 2018-08-23 PT PT187593082T patent/PT3672941T/pt unknown
-
2020
- 2020-02-20 IL IL272805A patent/IL272805B/en unknown
-
2021
- 2021-12-15 US US17/644,486 patent/US20220218688A1/en not_active Abandoned
-
2022
- 2022-04-25 IL IL292485A patent/IL292485B2/en unknown
- 2022-04-27 CY CY20221100305T patent/CY1125138T1/el unknown
- 2022-12-13 JP JP2022198540A patent/JP2023021276A/ja active Pending
-
2023
- 2023-10-31 AU AU2023258375A patent/AU2023258375A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017530999A5 (enExample) | ||
| RU2018137194A (ru) | Ингибиторы бромдомена | |
| JP2021119196A5 (enExample) | ||
| JP2014511869A5 (enExample) | ||
| JP2019521109A5 (enExample) | ||
| JP2016523911A5 (enExample) | ||
| JP2019505595A5 (enExample) | ||
| JP2015503529A5 (enExample) | ||
| JP2016517878A5 (enExample) | ||
| ME01507B (me) | Imidazotriazini i imidazopirimidini kao inhibitori kinaze | |
| JP2010513444A5 (enExample) | ||
| JP2007519754A5 (enExample) | ||
| JP2011526616A5 (enExample) | ||
| RU2012127760A (ru) | Bcl-2-селективные апоптоз-индуцирующие средства для лечения рака и иммунных заболеваний | |
| RU2015143191A (ru) | Дигидропирролопиридиновые ингибиторы бромодоменов | |
| JP2008500336A5 (enExample) | ||
| JP2017525757A5 (enExample) | ||
| JP2010533158A5 (enExample) | ||
| JP2016522246A5 (enExample) | ||
| JP2011520941A5 (enExample) | ||
| RU2006145205A (ru) | Терапевтические соединения: пиридин в качестве каркаса | |
| JP2016513660A5 (enExample) | ||
| RU2013145299A (ru) | Тиазолопиримидины | |
| JP2017512794A5 (enExample) | ||
| JP2009513575A5 (enExample) |